129 related articles for article (PubMed ID: 11742903)
1. Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.
Lee J; Aronchick JM; Alavi A
Chest; 2001 Dec; 120(6):1791-7. PubMed ID: 11742903
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Wax MK; Myers LL; Gabalski EC; Husain S; Gona JM; Nabi H
Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568
[TBL] [Abstract][Full Text] [Related]
4. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Bury T; Corhay JL; Duysinx B; Daenen F; Ghaye B; Barthelemy N; Rigo P; Bartsch P
Eur Respir J; 1999 Dec; 14(6):1376-80. PubMed ID: 10624770
[TBL] [Abstract][Full Text] [Related]
5. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
6. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
[TBL] [Abstract][Full Text] [Related]
8. Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Geraldson CT; Stephenson JE; Lagrew JP; Schammel CM; Schammel DP; Greene RA; Bolton WD
Am Surg; 2012 Mar; 78(3):305-8. PubMed ID: 22524768
[TBL] [Abstract][Full Text] [Related]
9. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
[TBL] [Abstract][Full Text] [Related]
10. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
11. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
12. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
Gupta NC; Tamim WJ; Graeber GG; Bishop HA; Hobbs GR
Chest; 2001 Aug; 120(2):521-7. PubMed ID: 11502653
[TBL] [Abstract][Full Text] [Related]
13. Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.
Pitman AG; Hicks RJ; Binns DS; Ware RE; Kalff V; McKenzie AF; Ball DL; MacManus MP
Br J Radiol; 2002 Feb; 75(890):114-21. PubMed ID: 11893634
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
Aukema TS; Valdés Olmos RA; Klomp HM; Teertstra HJ; Belderbos JS; Vogel WV; Baas P; Burgers SA; van den Heuvel MM
J Thorac Oncol; 2009 Oct; 4(10):1226-30. PubMed ID: 19687763
[TBL] [Abstract][Full Text] [Related]
15. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
16. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
[TBL] [Abstract][Full Text] [Related]
17. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
20. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
